The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes
- 1 June 2005
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 67 (6), 2346-2353
- https://doi.org/10.1111/j.1523-1755.2005.00340.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Pure Red-Cell Aplasia and Epoetin TherapyThe New England Journal of Medicine, 2004
- Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here?Nephrology Dialysis Transplantation, 2004
- Anti-Erythropoietin Antibodies and Pure Red Cell AplasiaJournal of the American Society of Nephrology, 2004
- Pure red-cell aplasia due to anti-erythropoietin antibodiesNephrology Dialysis Transplantation, 2003
- PRCA in a patient treated with epoetin betaNephrology Dialysis Transplantation, 2003
- Antibodies against rHuEPO: native and recombinant.Nephrology Dialysis Transplantation, 2002
- Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant ErythropoietinThe New England Journal of Medicine, 2002
- Immunogenicity of interferon-? in multiple sclerosis patients: Influence of preparation, dosage, dose frequency, and route of administrationAnnals of Neurology, 2000
- Antibodies against Recombinant Human Erythropoietin in a Patient with Erythropoietin-Resistant AnemiaThe New England Journal of Medicine, 1996